Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia

Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia

US Patent 10226478 · Granted Mar 12, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dosage regimen for sapacitabine and seliciclib2018
Dosing regimens for treatment of proliferative disorders comprising administrati2017
Dosing regimens for treatment of proliferative disorders comprising administrati2013
Methods of treatment using sapacitabine2012
Methods of treating Hodgkin's and non-Hodgkin's lymphoma2011
Methods of treating cancer2010
Polymorphs of suberoylanilide hydroxamic acid2008
Methods of treating cancer with HDAC inhibitors2008
Methods of treating cancer with HDAC inhibitors2008
Methods of treating mesothelioma with suberoylanilide hydroxamic acid2006